Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04798833
Other study ID # TTS181021048
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 7, 2021
Est. completion date June 2024

Study information

Verified date November 2023
Source The Hospital for Sick Children
Contact Shaun Morris, MD, MPH
Phone 416-813-7500 extension: 206625
Email shaun.morris@sickkids.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Neonatal deaths account for almost half of all deaths in children under 5 years of age. Pakistan has the world's highest neonatal mortality rate (NMR), and many of these deaths are preventable. In this study, the investigators propose the use of an evidence-based, integrated newborn care kit (iNCK) to promote safer delivery, provide early identification of danger signs, improve newborn health, and reduce NMR. The investigators hypothesize that use of the iNCK will result in at least a 25% reduction in NMR among participants who receive the iNCK compared with participants who do not receive the iNCK.


Description:

While some progress has been made towards reducing global under-5 mortality, in 2019, an estimated 2.4 million newborn deaths still occurred worldwide, accounting for 47% of all under-five deaths. Most neonatal deaths are caused by prematurity, sepsis, and intrapartum-related complications. Pakistan has the highest neonatal mortality rate (NMR) in the world, at 42 deaths per 1,000 live births. Gilgit-Baltistan (GB), Pakistan's remote, northern-most administrative territory, is afflicted with some of the country's worst NMRs. High rates of home deliveries, low adoption of safe birth practices, inadequate cord care, and high maternal mortality contribute to this health disparity. GB's geography, climate, and underdeveloped infrastructure also largely restrict access to health care facilities. Health care at the community level in Pakistan is primarily supported by the Lady Health Worker (LHW) Programme. LHWs form a cadre of government-supported community health workers who provide newborn and maternal health services in GB. However, each of these health care workers is responsible for approximately 1,000 people, which restricts both availability and comprehensiveness of care, particularly for families that live in hard to reach areas. Many proven, cost-effective ways to save newborn lives and improve wellbeing exist; however, they are not always available to those who need them most, nor are they packaged into a single portable kit that can be used in the home. An easy-to-use kit consisting of low cost, evidence-based interventions has potential to improve health status, reduce NMR, and provide more timely access to health services in remote areas such as GB. Between April 2014 and August 2015, the investigators conducted a community-based, cluster randomized intervention trial examining the effectiveness of delivering an integrated newborn care kit (iNCK) to pregnant women in Rahim Yar Khan (RYK), Punjab, Pakistan. The iNCKs were delivered by LHWs, who also educated participants how to use the different kit components. Neonatal mortality and morbidity outcomes were compared between iNCK recipients and a local control group who received the same standard of care, but no iNCK. The investigators found that while distribution of the iNCK did not significantly reduce neonatal mortality, utilization of the iNCK significantly reduced the risk of omphalitis and fever. Moreover, using the LHW network to distribute the intervention proved a feasible delivery mechanism. The findings from the RYK trial suggest that while a network of community health workers can reliably deliver integrated interventions to pregnant women, further investigation is needed to improve the integration of educational content and maximize the iNCK's potential health benefits. Moreover, effective delivery of maternal health interventions through the iNCK warrants examination, as Pakistan experiences some of the world's highest rates of maternal mortality, of which post-partum hemorrhage (PPH) is a leading cause.


Recruitment information / eligibility

Status Recruiting
Enrollment 27448
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Resides in a village with LHW coverage in participating union councils (clusters) in Astore, Diamer, Shigar, Ghanche, Kharmang, and Skardu, districts of GB, Pakistan - In their 3rd trimester of pregnancy (= week 27 gestational age) - Intends to be present in the study catchment area between day 29 and 35 postnatal age - Provides written informed consent or assent Exclusion Criteria: - Does not reside within the study's catchment area at the time of enrolment - Plans to relocate outside of the study catchment area within one month after the delivery of their newborn(s) and not return to the study catchment area - Does not provide written informed consent or assent - Lives in a village without LHW coverage

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Integrated Newborn Care Kit (iNCK)
Contents of the integrated newborn care kit: Clean birth kit: sterile blade, clean plastic sheet, plastic gloves, hand soap, cord ties/clamp, maternity pad to absorb post-natal bleeding, 10 cotton balls for applying Chlorhexidine (CHX) to the umbilical stump. 3x200 µg dissolvable tablets of misoprostol to be ingested prophylactically following delivery of the baby and before delivery of the placenta to prevent post-partum hemorrhage 4% CHX solution (15 mL) Sunflower oil emollient (50 mL) Temperature monitoring strip or sticker Fleece blanket for the newborn Click to heat warmer Pictorial guide that illustrates how and when to use each kit component Handheld electronic scale with suspended cloth sling (the scale will not be included with the kit but rather one will be issued to each Lady Health Worker in the experimental arm) Other Names: Neonatal Care Kit

Locations

Country Name City State
Pakistan Aga Khan Health Services, Pakistan Islamabad
Pakistan Aga Khan University Karachi

Sponsors (4)

Lead Sponsor Collaborator
The Hospital for Sick Children Aga Khan Health Services, Aga Khan University, The Aga Khan Foundation

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary All-cause neonatal mortality Death from any cause within the first 28 days of life Day 29 postnatal age
Secondary Cumulative incidence of omphalitis Cumulative incidence of omphalitis among neonates where omphalitis is defined as:
redness around the base of the baby's umbilical stump or surrounding skin OR
the presence of pus on or near the baby's umbilical stump
Day 29 postnatal age
Secondary Cumulative incidence of post-partum hemorrhage (PPH) Cumulative incidence of PPH is self-reported. PPH is defined as having experienced any of the following:
Post-delivery vaginal bleeding that pooled on the mattress/floor where the delivery took place
Having sought health care for post-delivery vaginal bleeding
Having received a blood transfusion after delivery
Having been diagnosed with PPH
Vaginal bleeding being reported as the cause of the mother's death
Day 29 postnatal age
Secondary Health facility utilization Self-reported health facility utilization by pregnant women, and/or neonates and mothers in the first month post-partum Day 29 postnatal age
Secondary Cumulative incidence of hypothermia among participants in the experimental arm Cumulative incidence of hypothermia defined by color change in temperature monitoring strip or sticker that indicates lower than normal temperature Day 29 postnatal age
Secondary Cumulative incidence of fever among participants in the experimental arm Cumulative incidence of fever defined by color change in temperature monitoring strip or sticker that indicates higher than normal temperature Day 29 postnatal age
Secondary Correlates of iNCK instructional compliance Correlates of iNCK instructional compliance, using a process analysis to explore the correlation between compliance and maternal, infant, sociodemographic characteristics, and Lady Health Worker teaching quality Day 29 postnatal age
Secondary Correlates of willingness to pay for the iNCK Explore the correlation between maternal, infant, and sociodemographic characteristics, and knowledge, attitudes, practice, and willingness to pay for the iNCK 29 postnatal age
Secondary Cause-specific neonatal mortality Death from specific causes within the first 28 days of life Day 29 postnatal age
See also
  Status Clinical Trial Phase
Completed NCT01215461 - Factors Associated With Mortality in Neonates N/A
Completed NCT02386592 - Prevention of Nosocomial Bacteremia Among Zambian Neonates N/A
Completed NCT01389219 - Post Partum Maternal and Neonatal Intervention Package N/A
Completed NCT00097097 - Neonatal Resuscitation in Zambia Phase 3
Completed NCT00109616 - Community Trial of Newborn Skin and Umbilical Cord Cleansing on Neonatal Mortality in Nepal Phase 3
Not yet recruiting NCT04904380 - Impact of New Tools of Simulation-enhanced Peer Learning on Neonatal and Maternal Mortality N/A
Completed NCT02208960 - Newborn Kit to Save Lives and Brains in Kenya Phase 3
Completed NCT01177111 - Impact of Sunflower Seed Oil Massage on Neonatal Mortality and Morbidity in Nepal Phase 3
Completed NCT00133744 - Impact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality Phase 3
Completed NCT01528852 - Chlorhexidine Cordcare for Reduction in Neonatal Mortality and Omphalitis Phase 3
Completed NCT03154177 - Group Antenatal/Postnatal Care in Rwanda N/A
Completed NCT00623337 - Ghana Newborn Home Visits Neonatal Mortality Trial Phase 3
Completed NCT00860470 - Antenatal Micronutrient Supplementation and Infant Survival Phase 3
Completed NCT00625482 - Sex-Differential Health Interventions In Low-Birth-Weight Infants N/A
Completed NCT01480544 - Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE) N/A
Completed NCT00418353 - Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL" N/A
Completed NCT02130856 - Newborn Kit to Save Lives in Pakistan Phase 3
Active, not recruiting NCT00148629 - Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women Phase 3